🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Solid Organ Transplant Complications

Host Genome Methylation: a Screening Tool in Anal Cancer Detection NCT06792604NA9 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Anal self-sampling (smear), HPV questionnaire BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants NCT06741072Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Dulbecco''s Phosphate-Buffered Saline, Peptide Vaccine, QS21 Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation NCT07291258n/a1 site📍 Groningen University Medical Center Groningen Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases NCT05318196n/a1 site📍 Toulouse University Hospital, Toulouse · Tests: Biological samples collection Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors NCT05159466n/a1 site📍 Metairie Tulane University · Tests: Kidney transplant Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in Solid Organ Transplant Recipients NCT06997471Phase 11 site📍 Madrid Francisco Hernández Oliveros · Tests: Investigational cellular therapy consisting on a HSCT using a graft enriched in CD34+, depleted of naïve T-lymphocytes … A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy NCT03394365Phase 371 sites📍 Duarte📍 La Jolla📍 Loma Linda Pierre Fabre Medicament · Tests: tabelecleucel Microbiota Transplantation in Solid Organ Transplantation NCT06730451n/a1 site📍 Nanjing The Second Hospital of Nanjing Medical University · Tests: Washed Microbiota Transplantation The Organ Transplant Recipient HPV and Skin Cancer Study NCT05284877n/a3 sites📍 Copenhagen NV📍 Hellerup📍 Roskilde Merete Haedersdal · Tests: No intervention
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy